Immune biomarkers for prognosis and prediction of responses to immune checkpoint blockade in cutaneous melanoma

Immune biomarkers for prognosis and prediction of responses to immune checkpoint blockade in cutaneous melanoma

Existing clinical, anatomopathological and molecular biomarkers fail to reliably predict the prognosis of cutaneous melanoma. Biomarkers for determining which patients receive adjuvant therapies are needed. The emergence of new technologies and the discovery of new immune populations with different...

Full description

Bibliographic Details
Main Authors: Nicolas Jacquelot, Jonathan M. Pitt, David P. Enot, Maria Paula Roberti, Connie P. M. Duong, Sylvie Rusakiewicz, Alexander M. Eggermont, Laurence Zitvogel
Format: Article
Language:English
Published: Taylor & Francis Group 2017-08-01
Series:OncoImmunology
Subjects:
immune biomarkers
immunotherapy
melanoma
predictive factors
prognostic factors
Online Access:http://dx.doi.org/10.1080/2162402X.2017.1299303

Internet

http://dx.doi.org/10.1080/2162402X.2017.1299303

Similar Items